Amundi Ani Pharmaceuticals Inc Transaction History
Amundi
- $276 Billion
- Q2 2025
A detailed history of Amundi transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Amundi holds 23,633 shares of ANIP stock, worth $2.11 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,633Holding current value
$2.11 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANIP
# of Institutions
243Shares Held
20MCall Options Held
19.9KPut Options Held
12.8K-
Black Rock Inc. New York, NY2.66MShares$237 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$114 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$89.5 Million0.03% of portfolio
-
Global Alpha Capital Management Ltd.862KShares$76.8 Million3.45% of portfolio
-
State Street Corp Boston, MA716KShares$63.8 Million0.0% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.55B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...